Table 2 Characteristics of patients
| Â | n=263 (M 162/F 101) | |
|---|---|---|
| Â | (n) | % |
No. of patients with a history of | ||
 Cerebrovascular disease | 24 | 9.1 |
 Coronary heart disease | 40 | 15.2 |
 Cardiac failure | 3 | 1.1 |
No. of patients using anti-diabetic drugs | ||
 Sulfonylureas | 96 | 36.5 |
 Glinides | 14 | 5.3 |
 Biguanides | 37 | 14.1 |
 Pioglitazone | 26 | 9.9 |
 α-Glucosidase inhibitors | 66 | 25.1 |
 Insulin | 54 | 20.5 |
